Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #11 of 33 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Based on Rainbow Childrens Medicare Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Quarter: Q2 FY27 - Revenue from operations: INR 5,480.2 Mn - Revenue Q2 FY26: INR 4,448.0 Mn - Year-on-year (YoY) growth in revenue: 23.2% - Volume-related operational KPIs for Q2 FY27: - IP Discharges: 2,555 (up 12% YoY) - OP Consultations: 5,07,114 (up 19% YoY) - Deliveries: 5,719 (up 20% YoY) - EBITDA for Q2 FY27: INR 1,699.8 Mn (Post Ind AS 116, excluding other income), representing a 14.2% YoY growth (Page 14).
From Rainbow Childrens Medicare Ltd's Q2 FY27 earnings-call transcript · updated 31 Oct 2026.
Revenue & Sales Performance
- Quarter: Q2 FY27
- Revenue from operations: INR 5,480.2 Mn
- Revenue Q2 FY26: INR 4,448.0 Mn
- Year-on-year (YoY) growth in revenue: 23.2%
- Volume-related operational KPIs for Q2 FY27:
- IP Discharges: 2,555 (up 12% YoY)
2 more points from Rainbow Childrens Medicare Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Rainbow Childrens Medicare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Telangana beds expansion includes acquisition of Prashanthi Hospital, Warangal.
- Coimbatore hospital expected to commission by H2 FY27-28.
- Nellore (70 beds) and Guntur (50 beds) hospitals commissioned from 1st September 2026.
- Indore: Currently 25 beds operational; ~100 beds independent facility likely by end FY29.
- Mumbai hospital likely to commence by Q1 FY28.
- Madhukar hospital beds (130) included where Rainbow provides medical services.
- Indicative bed additions and timelines:
- FY26-27: 25 beds
- FY27-28: 385 beds
- FY28-29: 630 beds
- FY29-30: 150 beds
- FY30: 1,190 beds
- FY32: ~1,125 beds
2 more points from Rainbow Childrens Medicare Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Rainbow Childrens Medicare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Rainbow Childrens Medicare Ltd said on order book & pipeline — free account, 30 seconds.
Rainbow Childrens Medicare Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹460 Cr, net profit ₹78 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Rainbow Childrens Medicare Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Narayana Hrudayalaya Ltd (Q2 FY27)
Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27
- Artemis Medicare Services Ltd (Q2 FY27)
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service
- Max Healthcare Institute Ltd (Q2 FY27)
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio
- Indegene Ltd (Q2 FY27)
Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4) . Key investor presentation takeaways from Indegene Ltd's Q2 FY27 investo
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Rainbow Childrens Medicare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Rainbow Childrens Medicare Ltd Q2 FY27 results?
Quarter: Q2 FY27 - Revenue from operations: INR 5,480.2 Mn - Revenue Q2 FY26: INR 4,448.0 Mn - Year-on-year (YoY) growth in revenue: 23.2% - Volume-related operational KPIs for Q2 FY27: - IP Discharges: 2,555 (up 12% YoY) - OP Consultations: 5,07,114 (up 19% YoY) - Deliveries: 5,719 (up 20% YoY) - EBITDA for Q2 FY27: INR 1,699.8 Mn (Post Ind AS 116, excluding other income), representing a 14.2% YoY growth (Page 14).
What is Rainbow Childrens Medicare Ltd share price analysis?
Rainbow Childrens Medicare Ltd currently shows a neutral. The stock trades at a P/E of 43.2 with a market cap of ₹12,377 Cr. Investors should review the full earnings analysis for detailed insights.
Is Rainbow Childrens Medicare Ltd planning capital expenditure?
Telangana beds expansion includes acquisition of Prashanthi Hospital, Warangal.
Keep Rainbow Childrens Medicare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.